000 | 01492 a2200397 4500 | ||
---|---|---|---|
005 | 20250513160548.0 | ||
264 | 0 | _c19990128 | |
008 | 199901s 0 0 eng d | ||
022 | _a0960-894X | ||
024 | 7 |
_a10.1016/s0960-894x(98)00377-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHanessian, S | |
245 | 0 | 0 |
_aProbing the importance of spacial and conformational domains in captopril analogs for angiotensin converting enzyme activity. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _cAug 1998 |
||
300 |
_a2123-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xchemistry |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCaptopril _xanalogs & derivatives |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aIndicators and Reagents |
650 | 0 | 4 | _aIsomerism |
650 | 0 | 4 |
_aLung _xenzymology |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 | _aMolecular Conformation |
650 | 0 | 4 |
_aPeptidyl-Dipeptidase A _xisolation & purification |
650 | 0 | 4 |
_aProline _xanalogs & derivatives |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 |
_aRamipril _xanalogs & derivatives |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aReinhold, U | |
700 | 1 | _aSaulnier, M | |
700 | 1 | _aClaridge, S | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 8 _gno. 16 _gp. 2123-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0960-894x(98)00377-1 _zAvailable from publisher's website |
999 |
_c9835916 _d9835916 |